BRCA2 and neoplasm: Here, we report using structure-guided lead discovery the development of a potent orthosteric inhibitor, CAM833, of the protein-protein interaction between the BRCA2 tumor suppressor and the RAD51 recombinase, which is critical for the error-free repair of DNA breakage by homologous DNA recombination.